Inmed Pharmaceuticals In (IN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 24 | 25 | 22 | 24 | 22 |
| Accounts receivable | -6 | -23 | -20 | 26 | -2 |
| Accounts payable and accrued liabilities | N/A | 82 | -16 | -269 | 226 |
| Other Working Capital | 838 | -161 | -144 | -249 | 98 |
| Other Operating Activity | -2,770 | -2,062 | -1,135 | -864 | -1,337 |
| Operating Cash Flow | $-1,915 | $-2,139 | $-1,293 | $-1,333 | $-993 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14 | -4 | -7 | -2 | 1 |
| Other Investing Activity | 1,688 | -74 | 200 | -3,892 | 33 |
| Investing Cash Flow | $1,674 | $-78 | $193 | $-3,894 | $33 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 54 | 145 | 0 | 9 | 11,547 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -1,086 |
| Financing Cash Flow | $54 | $145 | $0 | $9 | $10,461 |
| Beginning Cash Position | 9,685 | 11,400 | 13,461 | 18,680 | 8,944 |
| End Cash Position | 9,806 | 9,685 | 11,400 | 13,461 | 18,350 |
| Net Cash Flow | $-187 | $-2,072 | $-1,101 | $-5,218 | $9,501 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,915 | -2,139 | -1,293 | -1,333 | -993 |
| Capital Expenditure | -14 | -4 | -7 | -2 | N/A |
| Free Cash Flow | -1,929 | -2,143 | -1,300 | -1,335 | -993 |